Therefore, YAP1 may be an effective predictor of digestion molecular markers for surviving systemic malignancies, especially pancreatic cancer, which can provide a new target for the treatment of digestive system tumors such as pancreatic cancer. This evidence concerns the gene YAP1 and familial pancreatic carcinoma.